At a glance
- Originator Roche Palo Alto LLC
- Class Antidepressants; Antihypertensives; Naphthyridines; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Undefined in USA (unspecified route)
- 14 Dec 2000 No-Development-Reported for Undefined in USA (Unknown route)
- 10 Jul 1997 New profile